2024 2nd quarter earnings conference call

Written By Kevin Jirka

  • Reports record revenue of $16.5 million for the third quarter of 2023.

  • GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.

  • Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022.

Kevin Jirka
Previous

IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Next

2024 1st quarter earnings conference call